Year | Month | BMI | Treatment | Dose | Performance status |
---|---|---|---|---|---|
2011 | 31.2 | ||||
2013 | Feb | 29.4 | FLOX C1 | Oxaliplatin: 150 mg Fluorouracil: 950 mg Calciumfolinat: 110 mg | 0 |
March | 28.7 | FLOX C2 | Oxaliplatin: 140 mg Fluorouracil: 900 mg Calciumfolinat: 100 mg | 1 | |
April | 27.8 | FLOX C3 | Oxaliplatin: 120 mg Fluorouracil: 720 mg Calciumfolinat: 100 mg | 1 | |
June | 29.2 | Capecitabine | 500mgx1 | 1-2 | |
July | Capecitabine/ Bevacizumab C1 | 500 mg × 2/ 350 mg | 1-2 | ||
Aug | Capecitabine/ Bevacizumab C2 | 500 mg × 2/ 350 mg | 0-1 | ||
Capecitabine/ Bevacizumab C3 | 500 mg × 2/ 350 mg | ||||
Sept | Capecitabine/ Bevacizumab C4 | 500 mg × 2/ 350 mg | |||
Capecitabine/ Bevacizumab C5 | 500 mg × 2/ 350 mg | ||||
Oct | 29.8 | Capecitabine/ Bevacizumab C6 | 500 mg × 2/ 350 mg | 0-1 | |
Capecitabine/ Bevacizumab C7 | 500 mg × 2/ 350 mg | ||||
2014 | Jan | 31.2 | 0 |